NovoCure (NVCR) EBT Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,776.00 |
| Dec 31, 2025 | -2,962.00 |
| Sep 30, 2025 | -2,628.00 |
| Jun 30, 2025 | -2,552.00 |
| Mar 31, 2025 | -1,384.00 |
| Dec 31, 2024 | -3,263.00 |
| Sep 30, 2024 | -1,533.00 |
| Jun 30, 2024 | -1,507.00 |
| Mar 31, 2024 | -1,127.00 |
| Dec 31, 2023 | -1,327.00 |
| Sep 30, 2023 | -2,607.00 |
| Jun 30, 2023 | -2,660.00 |
| Mar 31, 2023 | -818.00 |
| Dec 31, 2022 | -1,251.00 |
| Sep 30, 2022 | -176.00 |
| Jun 30, 2022 | 2,958.00 |
| Mar 31, 2022 | 4,352.00 |
| Dec 31, 2021 | -21,839.00 |
| Sep 30, 2021 | 13,263.00 |
| Jun 30, 2021 | 20,099.00 |
| Mar 31, 2021 | 24,686.00 |
| Dec 31, 2020 | 26,035.00 |
| Sep 30, 2020 | 28,808.00 |
| Jun 30, 2020 | 43,269.00 |
| Mar 31, 2020 | 42,703.00 |
| Dec 31, 2019 | -92,828.00 |
| Sep 30, 2019 | 41,197.00 |